Endometrial cancer (EC) is a prevalent uterine cancer that remains a major contributor to
cancer-associated morbidity and mortality. EC diagnosed at advanced stages shows a poor …

Endometrial cancer is the most common malignancy of the female genital tract and its
incidence is rising in parallel with the mounting prevalence of obesity. Early diagnosis has …

Gynecological cancers including breast, cervical, ovarian, uterine, and vaginal, pose the
greatest threat to world health, with early identification being crucial to patient outcomes and …

PURPOSE Endometrial cancer (EC) incidence has been rising over the past 10 years.
Delays in diagnosis reduce survival and necessitate more aggressive treatment. We aimed …

Due to diagnostic improvements, medical diagnostics is demanding non-invasive or
minimally invasive methods. Non-invasively obtained body fluids (eg., Urine, serum) can …

Metabolic reprogramming is increasingly recognised as one of the defining hallmarks of
tumorigenesis. There is compelling evidence to suggest that endometrial cancer develops …

Background The incidence of endometrial cancer is rising, and current diagnostics often
require invasive biopsy procedures. Urine may offer an alternative sample type, which is …

Cervico‐vaginal cytology is primarily a cervical cancer screening test. The anatomical
continuity of the uterine cavity with the cervix makes the Papanicolaou (Pap) test accessible …

Endometrial cancer (EC) rates are continuing to rise and it remains the most common
gynecologic cancer in the US. Existing diagnostic methods are invasive and can cause pain …

Simple Summary This review deals with the prospects of early diagnostics in cervical,
endometrial, and ovarian cancers. Progress in cancer research has enabled the rapid …